MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF THE EFFICACY AND TOLERABILITY OF APALUTAMIDE AND DAROLUTAMIDE FOR THE TREATMENT OF NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)

被引：0
|
作者：
Chowdhury, S. [1 ,2 ,3 ]
Oudard, S. [4 ]
Uemura, H. [5 ]
Joniau, S. [6 ]
Liu, J. [7 ]
Dearden, L. [8 ]
Sermon, J. [9 ]
Van Sanden, S. [9 ]
Diels, J. [9 ]
Hadaschik, B. A. [10 ,11 ]
机构：
[1] Guys Hosp, London, England
[2] Kings Hosp, London, England
[3] St Thomas Hosp, London, England
[4] Georges Pompidou Hosp, Paris, France
[5] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan
[6] Univ Hosp Leuven, Leuven, Belgium
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Janssen Global Serv, Raritan, NJ USA
[9] Janssen EMEA, Beerse, Belgium
[10] Univ Duisburg Essen, Essen, Germany
[11] German Canc Consortium DKTK, Partner Site Univ Hosp Essen, Essen, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CL4
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [1] Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
    Simon Chowdhury
    Stephane Oudard
    Hiroji Uemura
    Steven Joniau
    Lindsay Dearden
    Camille Capone
    Suzy Van Sanden
    Joris Diels
    Boris A. Hadaschik
    Advances in Therapy, 2022, 39 : 518 - 531
  • [2] Safety outcomes of darolutamide versus apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC): Matching-adjusted indirect comparisons.
    Jiang, Shan
    Terasawa, Emi
    Horton, Viviana Garcia
    Ayyagari, Rajeev
    Waldeck, A. Reginald
    Halabi, Susan
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
    Chowdhury, Simon
    Oudard, Stephane
    Uemura, Hiroji
    Joniau, Steven
    Dearden, Lindsay
    Capone, Camille
    Van Sanden, Suzy
    Diels, Joris
    Hadaschik, Boris A.
    ADVANCES IN THERAPY, 2022, 39 (01) : 518 - 531
  • [4] Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Tombal, B.
    Sternberg, C. N.
    Hussain, M.
    Ganguli, A.
    Li, Y.
    Sandin, R.
    Bhadauria, H.
    Oh, M.
    Saad, F.
    ESMO OPEN, 2022, 7 (03)
  • [5] Apalutamide compared with darolutamide for the treatment of non-metastatic castration resistant prostate cancer: efficacy and tolerability in a matching-adjusted indirect comparison
    Chowdhury, S.
    Oudard, S.
    Uemura, H.
    Joniau, S.
    Dearden, L.
    Capone, C.
    Van Sanden, S.
    Diels, J.
    Hadaschik, B. A.
    ONKOUROLOGIYA, 2022, 18 (01): : 77 - 89
  • [6] Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
    Cattrini, Carlo
    Caffo, Orazio
    De Giorgi, Ugo
    Mennitto, Alessia
    Gennari, Alessandra
    Olmos, David
    Castro, Elena
    CANCERS, 2022, 14 (07)
  • [7] Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
    Halabi, Susan
    Jiang, Shan
    Terasawa, Emi
    Garcia-Horton, Viviana
    Ayyagari, Rajeev
    Waldeck, A. Reginald
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 (02): : 298 - 307
  • [8] MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF APALUTAMIDE AND ENZALUTAMIDE IN THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Chowdhury, S.
    Oudard, S.
    Hadaschik, B. A.
    Uemura, H.
    Joniau, S.
    Pilon, D.
    Ladouceur, M.
    Behl, A.
    Liu, J.
    Dearden, L.
    Sermon, J.
    Van Sanden, S.
    Diels, J.
    VALUE IN HEALTH, 2018, 21 : S20 - S21
  • [9] Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
    Chowdhury, Simon
    Oudard, Stephane
    Uemura, Hiroji
    Joniau, Steven
    Pilon, Dominic
    Ladouceur, Martin
    Behl, Ajay S.
    Liu, Jinan
    Dearden, Lindsay
    Sermon, Jan
    Van Sanden, Suzy
    Diels, Joris
    Hadaschik, Boris A.
    ADVANCES IN THERAPY, 2020, 37 (01) : 501 - 511
  • [10] Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
    Simon Chowdhury
    Stéphane Oudard
    Hiroji Uemura
    Steven Joniau
    Dominic Pilon
    Martin Ladouceur
    Ajay S. Behl
    Jinan Liu
    Lindsay Dearden
    Jan Sermon
    Suzy Van Sanden
    Joris Diels
    Boris A. Hadaschik
    Advances in Therapy, 2020, 37 : 501 - 511
12345